To scale-up TB preventive therapy, we need to bundle tools & improve access

By Madhukar Pai | 19 Nov, 2018

Please see this blog post:

There is growing expectation on countries to scale-up preventive therapy, but our LTBI toolbox is currently broken. Shortage of tuberculin, expensive X-ray hardware, limited access to IGRAs, and lack of registration of rifapentine pose big barriers for high-burden countries to scale-up preventive therapy.

I think it might be helpful if major agencies and stakeholders convened all LTBI product manufacturers, negotiate a 'bundled price' & address supply chain problems.